Objectives: To evaluate the contribution of the results of sacroiliac imaging to diagnosis and to the level of confidence in diagnosis in patients presenting with chronic back pain (CBP) and suspected of having axial spondyloarthritis (axSpA).
Introduction
The diagnosis of axial spondyloarthritis (axSpA) in patients presenting with chronic back pain (CBP) is a known challenge in clinical practice as there is a broad spectrum in clinical presentations [1] . Rheumatologists may use information acquired from several sources such as a patient's medical history, physical examination, laboratory tests and imaging (radiography and/or magnetic resonance imaging of sacroiliac joints) to make a diagnosis [24] .
Several decades ago, conventional radiography was introduced as an imaging tool to detect sacroiliitis [5] . However, pelvic radiographs can only detect structural changes such as erosions and sclerosis. Furthermore, in early axSpA radiography of the sacroiliac joints may not show structural abnormalities, which can remain absent for many years after disease onset [6] . In recent years, MRI has become an important instrument in the visualization of both inflammation and structural damage in CBP patients especially without radiographic sacroiliitis [711] .
Imaging of the sacroiliac joints plays a pivotal role in the early recognition of axSpA [12, 13] . We have recently shown that in CBP patients suspected of axSpA, positive imaging of the sacroiliac joints is highly associated with a diagnosis of axSpA (odds ratio = 34.3; 95% CI: 17.3, 67.7) [14] .
Unfortunately, recognition of sacroiliitis on radiographs can be difficult. For example, it has been shown that agreement on radiographic sacroiliitis between readers is low and that this does not improve after training [15] . Moreover, bone marrow oedema on MRI suggestive of axSpA may not always be due to axSpA [16] . Therefore, some axSpA experts have expressed their concerns about relying solely on imaging, which may lead to incorrect diagnoses of axSpA. In turn, this may lead to unnecessary exposure to anti-inflammatory drugs with potentially severe side effects [17, 18] .
Given these controversies, surprisingly little is known about how rheumatologists actually integrate sacroiliac imaging results in their diagnostic work-up of CBP patients suspected of having axSpA. Therefore, the main objectives of this study were to study the contribution of sacroiliac imaging to the rheumatologist's diagnosis, and to quantify the contribution of sacroiliac imaging to diagnostic certainty.
Methods

Study design and population
The data used for the current study were obtained from the SPondyloArthritis Caught Early (SPACE) cohort. The SPACE cohort is a prospective multicentre study, which was initiated in January 2009. A detailed description of the study design has been published previously [19] .
Briefly, patients with CBP (53 months and 42 years) of unknown origin and age of onset <45 years were recruited and included from multiple European rheumatology centres in the Netherlands, Norway, Italy and Sweden. The clinical database used for the current study was locked on 11 January 2017.
Approval for the study was obtained from the local medical ethical committee of the Leiden University Medical Center (reference number: P08.105); patients provided written informed consent before participation.
Clinical assessments and measurements
All patients were examined according to a standardized full work-up including the assessment of the presence and history of clinical SpA features according to the Assessment of Spondyloarthritis international Society (ASAS) definitions [3] : CRP/ESR, HLA-B27, inflammatory back pain, good response to NSAIDs, positive family history of SpA, peripheral arthritis, dactylitis, heel enthesitis, acute anterior uveitis, IBD and psoriasis.
Imaging of the sacroiliac joints
Plain radiographs of the pelvis (X-SI) were performed in anteroposterior view. MRI of sacroiliac joints (MRI-SI) was performed in coronal oblique T1-weighted turbo spin echo and short tau inversion recovery with a slice thickness of 4 mm. Interpretation of the radiographs and MRI of the sacroiliac joints (sacroiliitis yes/no) was done by each participating centre as part of routine clinical practice (local reading). Patients were classified according to the ASAS classification criteria for which data from central reading in the SPACE cohort was used [20] .
Diagnosis
During the diagnostic work-up, rheumatologists were asked to provide a diagnosis twice (axSpA, yes/no): based only on information available after medical history, physical examination and laboratory testing, but before taking sacroiliac imaging into account (diagnosis before imaging), and based on all previously collected information but after taking sacroiliac imaging into account (diagnosis after imaging). In case of no axSpA, rheumatologists were asked to provide the most likely alternative diagnosis. In addition, rheumatologists were requested to provide a level of confidence (LoC) regarding their diagnosis Values are listed as n (%), unless otherwise stated. a n = 510 patients for HLA-B27.
b n = 499 patients for good response to NSAIDs. axSpA: axial spondyloarthritis; IBP: inflammatory back pain.
(axSpA or no axSpA) on an 11-point numerical rating scale ranging from 0 (not confident at all) to 10 (very confident).
Data analysis
For the present study baseline patients with complete information on sacroiliac imaging (both MRI and radiography) and diagnosis were analysed. Descriptive statistics were used to define patient characteristics for the total patient group, for each diagnosis subgroup (axSpA vs no axSpA), and for each imaging subgroup (i.e. sacroiliitis positive and negative) as means (S.D.) for continuous variables or frequencies (%) for categorical variables. Chi-square and unpaired t tests were used to compare variables between groups. The paired t test was used to compare the level of confidence regarding diagnosis before and after imaging within each diagnosis subgroup according to their imaging status. Total number of SpA features was calculated including HLA-B27 status, but without taking imaging of the sacroiliac joints into account. Any positive imaging was defined as one of a negative X-SI but positive MRI-SI (X-SI À /MRI-SI + ), a positive X-SI but negative MRI-SI (X-SI + /MRI-SI À ) or sacroiliitis on both modalities (X-SI + /MRI-SI + ). The rheumatologist's diagnosis and the LoC regarding diagnosis were the main outcomes. Data analysis was performed using Stata SE v.14 software (StataCorp LP, College Station, TX, USA).
Results
Baseline data of 583 CBP patients were available. A total of 70 (12%) patients were excluded because of incomplete or missing data regarding diagnosis or sacroiliac imaging. Baseline characteristics of these patients were similar to the remaining 513 patients with complete data (data not shown). Of these 513 CBP patients suspected of having axSpA, 188 (37%) patients were male, mean age (S.D.) was 31.0 (8.2) years, mean symptom duration was 13.3 (7.0) months and 210 (41%) patients were HLA-B27 positive (Table 1) . In all patients, rheumatologists provided a diagnosis before and after taking sacroiliac imaging into account (Fig. 1) . Before imaging, 317 (62%) patients were diagnosed with axSpA (Table 2 ). Most common diagnoses in the 196 patients without axSpA were non-specific back pain, degenerative disc disease and mechanical back pain (data not shown). Diagnostic confidence was moderate in patients with and without an axSpA diagnosis before imaging [mean (S.D.) LoC axSpA 6.6 (1.9) and mean LoC no axSpA 5.6 (2.0), respectively]. Patients diagnosed with axSpA before imaging were more often male (41% vs 29%) and were more often HLA-B27 positive (53% vs 22%) compared with patients who were not diagnosed with axSpA before imaging. As expected, the mean (S.D.) number of SpA features was twice as high for axSpA patients compared with the patients not diagnosed with axSpA [3.1 (1.7) and 1.5 (1.0), respectively].
FIG. 1 Rheumatologist's diagnosis before and after considering imaging of sacroiliac joints (n = 513)
Any positive imaging defined as sacroiliitis on MRI and/or radiographic sacroiliitis; imaging negative defined as no abnormalities on MRI and radiographs of sacroiliac joints. Boxes in bold represent patients with a change in diagnosis due to imaging results discordant with the diagnosis before imaging. axSpA: axial spondyloarthritis.
In total, 317/513 (62%) of CBP patients were initially diagnosed with axSpA, and this figure decreased to 269/513 (52%) patients with a final diagnosis of axSpA after imaging. Of these 269 axSpA patients, 55% were male, 59% were HLA-B27 positive, 62% had positive imaging and the mean number of SpA features was 3.2 (1.7). A total of 172/269 (64%) patients fulfilled the ASAS classification criteria [52% male, 87% HLA-B27 positive and mean number of SpA features 3.2 (1.5)]. Overall, the mean diagnostic confidence increased by having imaging results available (from 6.2 to 7.4, P < 0.001). This increase in diagnostic confidence was observed in both axSpA patients [from 7.1 (1.7) to 7.7 (2.1), P < 0.001] and nonaxSpA patients [from 5.7 (2.0) to 7.5 (2.3), P < 0.001].
Of the 317 patients who were diagnosed with axSpA before imaging, 139 (44%) had positive imaging (Table 3) . In these 139 patients, sacroiliitis was seen in 85 (61%) patients only on MRI-SI, in 10 (7%) patients only on X-SI and in 44 (32%) patients on both modalities (X-SI + /MRI-SI + ). After imaging, the axSpA diagnosis was maintained in all of these 139 patients and the mean LoC in the diagnosis of axSpA increased significantly [from 7.4 (1.8) to 8.6 (1.7), P < 0.001].
Of the 317 patients who were diagnosed with axSpA before imaging, 178 (56%) had negative imaging. In 97/178 patients the diagnosis axSpA was maintained. In these patients, the LoC in the diagnosis somewhat decreased [from 6.7 (1.6) to 6.4 (2.1), P = 0.06]. In 81/178 patients with negative imaging the diagnosis was changed to no axSpA after imaging. In these patients the LoC increased significantly after imaging [from 5.1 (1.7) to 6.4 (2.0), P < 0.001]. By comparison, the 97/178 patients diagnosed with axSpA after imaging had a higher number of SpA features (excluding imaging and HLA-B27) than the 81/178 patients without axSpA [mean 3.5 (1.6) vs 2.2 (1.2), P < 0.001]. Moreover, these 97 axSpA patients were also more often HLA-B27 positive than the 81 patients without axSpA (53% vs 33%, P = 0.010).
Of the 196 patients not diagnosed with axSpA before imaging, 35 (18%) had positive imaging (Table 4) . In these 35 patients, sacroiliitis was seen in 24 (68%) patients only on MRI-SI, in 2 (6%) patients only on X-SI and in 9 (26%) patients on both modalities (X-SI + /MRI-SI + ). Moreover, these 28 patients diagnosed with axSpA were also more often HLA-B27 positive than the seven patients without axSpA (48% vs 29%, P = 0.35). Of the 196 patients not diagnosed with axSpA before imaging, 161 (82%) had negative imaging. Despite having negative imaging, the diagnosis changed to axSpA after imaging in 5/196 patients (3%). In these five patients, LoC in diagnosis increased [from 5.0 (1.9) to 6.4 (1.9), P = 0.43]. In 156/161 (97%) patients with negative imaging, the diagnosis no axSpA remained unchanged. The LoC in diagnosis increased after imaging [from 5.8 (2.0) to 7.6 (2.2), P < 0.001]. By comparison, the 5/161 patients diagnosed with axSpA after imaging had a higher number of SpA features than the 156/161 patients without axSpA [mean 1.8 (0.8) vs 1.4 (1.0), P = 0.43]. Moreover, these 5 axSpA patients were also more often HLA-B27 positive than the 156 patients without axSpA (40% vs 16%, P = 0.16).
In the entire cohort, the diagnosis changed in 21% (109/513) of the CBP patients following imaging. In patients with imaging results that were discordant with their primary diagnosis [n = 213 (178 + 35)], the diagnosis changed in 109 (51%) patients (Fig. 1, boxes in bold) . This change of diagnosis more often pertained to patients in whom a clinical diagnosis was suspected but imaging was negative [81/109 (74%)] than in patients in whom a clinical (20) Values are listed as n (%), unless otherwise stated. LoC, level of confidence regarding diagnosis: 0 (not confident at all) through 10 (very confident). a n = 315 for patients with axSpA diagnosis before imaging. 
Discussion
This study was performed to investigate the contribution of sacroiliac imaging to the rheumatologist's diagnosis and its respective confidence. We have shown that the rheumatologist's confidence in the diagnosis of patients with CBP suspected of having axSpA increases after the results of sacroiliac imaging are taken into account. However, the number of changes in diagnosis after imaging implies that imaging is indeed an important but not the all-decisive factor in axSpA diagnosis.
Prior to imaging the physician's confidence in diagnosis was already moderate to high in most patients, which corroborates the value of medical history taking, physical examination and laboratory tests in the diagnostic workup of axSpA. Congruent imaging results significantly increased the diagnostic confidence of rheumatologists except in axSpA patients (before and after imaging) without sacroiliitis. In general, these findings are in line with results from an international survey conducted among rheumatologists throughout the world illustrating the value rheumatologists place on imaging in the diagnostic work-up of patients suspected of axSpA [21] .
Nevertheless, there were patients diagnosed as no axSpA before imaging in which a positive imaging result did not influence the final diagnosis. A few patients were not diagnosed with axSpA after imaging, even though they had sacroiliitis (n = 6 for MRI-SI and n = 1 for X-SI). These patients had only a few other SpA features and rheumatologists remained uncertain about the diagnosis (mean LoC 5.0). Apparently, the diagnosing rheumatologist considered the observed lesions-in combination with the clinical presentation-not sufficiently specific for an axSpA diagnosis, which is an indication that rheumatologists do not necessarily find that imaging is the dominant feature in establishing a diagnosis of axSpA. An even smaller number of patients (n = 5) without a diagnosis of axSpA before imaging and without signs of sacroiliitis were still diagnosed with axSpA after imaging. Since these five patients have a low number of SpA features, it is difficult to understand these diagnoses. Moreover, our findings also stress the importance of imaging in rejecting an axSpA diagnosis as in 81/178 (46%) patients with axSpA before imaging, the diagnosis was dismissed when imaging turned out to be negative.
This study has several limitations. First, rheumatologists were asked to provide CBP patients with a diagnosis before and after taking imaging into account. We cannot, however, rule out the possibility that rheumatologists may have already looked at the imaging results https://academic.oup.com/rheumatology before filling out the diagnosis in the case report form. However, this does not explain why change in diagnosis still occurred. More importantly, the overall diagnostic confidence clearly increased after taking imaging results into account, which most likely would not have happened (or to a lesser extent) if rheumatologists had indeed looked at the imaging results before filling out the diagnosis before imaging. Although in line with clinical practice, the fact that each patient was diagnosed by one rheumatologist and the imaging was read by one radiologist might be regarded as a limitation. Furthermore, the rheumatologist may also have used information from other sources such as spinal imaging in the diagnostic process, which may have (additionally) contributed to the LoC regarding the diagnosis. In addition, due to the high overlap of positive imaging (i.e. X-SI + /MRI-SI + ), we cannot elaborate on the individual value of each modality (X-SI or MRI-SI) on the final diagnosis and the diagnostic confidence. In conclusion, in CBP patients suspected of having axSpA, sacroiliac imaging increases diagnostic confidence. However, the number of changes in diagnosis suggests that imaging is important but not all-decisive in the early diagnosis of axSpA.
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